Literature DB >> 14581578

Amino acid sequences within the beta1 domain of human apolipoprotein B can mediate rapid intracellular degradation.

Louis R Lapierre1, Deborah L Currie, Zemin Yao, Jianjun Wang, Roger S McLeod.   

Abstract

Apolipoprotein B (apoB)-48 contains a region termed the beta1 domain that is predicted to be composed of extensive amphipathic beta-strands. Analysis of truncated apoB variants revealed that sequences between the carboxyl termini of apoB-37 and apoB-42 governed the secretion efficiency and intracellular stability of apoB. Although apoB-37, apoB-34, and apoB-29 were stable and secreted efficiently, apoB-42 and apoB-100 were secreted poorly and were degraded by an acetyl-leucyl-leucyl-norleucinal (ALLN)-sensitive pathway. Amino acid sequence analysis suggested that a segment between the carboxyl termini of apoB-38 and apoB-42 was 63% homologous to fatty acid binding proteins (FABPs), which contain orthogonal beta-sheets. To test the hypothesis that sequences from the beta1 domain are involved in apoB degradation, fusion proteins were created that contained apoB-29 linked to fragments derived from the beta1 domain of apoB or to liver FABP. Fusion proteins containing the beta1 domain segments apoB-34-42 or apoB-37-42 were degraded rapidly, whereas other fusion proteins were stable and secreted efficiently. Degradation was ALLN-sensitive, and the apoB-34-42 segment increased the association of the apoB protein with the cytosolic surface of the microsomal membrane. Our data suggest that the presence of specific sequences in the beta1 domain of human apoB increases degradation by promoting the cytosolic exposure of the protein, although not all regions of the beta1 domain are functionally equivalent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581578     DOI: 10.1194/jlr.M300104-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.

Authors:  Eric A Fisher; Neeraj A Khanna; Roger S McLeod
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

Review 2.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.

Authors:  Eric Fisher; Elizabeth Lake; Roger S McLeod
Journal:  J Biomed Res       Date:  2014-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.